Story type: Discovery

  • One-two punch targets childhood brain cancer

    The latest discovery packs a double punch – identifying a genetic target for childhood brain cancer, plus a way to determine which patients are mostly likely to benefit from it.…  Read more

    Dr Paul Daniel, Dr Shazia Adjumain and Professor Ron Firestein

  • Extracellular vesicles: A promising frontier in treating preterm brain injury

    Despite advances in neonatal care, effective treatments for brain injury in premature babies remain a significant unmet need. Researchers at Hudson Institute of Medical Research, working with the School of Clinical Sciences at Monash Health, are tackling this challenge head-on with an innovative approach: engineered extracellular vesicles.…  Read more

    Tamara Yawno International Women’s Day

  • Leader cells key to stopping ovarian cancer’s double impact

    A diagnosis of ovarian cancer carries a dual threat – the disease itself and the danger of the cancer spreading – but the latest research from Hudson Institute has uncovered a crucial factor, leader cells, that are crucial to both.…  Read more

    An advanced-stage tumor after 8 weeks, showing specific areas where cancer-spreading leader cells (KRT14+ LCs) and immune-suppressing cells (Tregs) are concentrated, driving tumor growth and immune evasion

  • Creatine & pregnancy – good for baby’s brain

    There is growing evidence that creatine may be beneficial as a pregnancy supplement, and new research from Hudson Institute suggests it could have benefits in protecting the brain when a baby is starved of oxygen.…  Read more

    Dr Robert Galinsky and Ms Nhi Tran from the Perinatal Transition Research Group at Hudson Institute

  • AI-based fetal monitoring to prevent perinatal brain injury

    A new AI-driven approach to fetal brain health monitoring will enable early detection of fetal distress, allowing for timely interventions to prevent brain damage and reducing unnecessary medical interventions, thanks to Monash Institute of Medical Engineering (MIME) project grant support.…  Read more

    Baby fetal brain monitoring sq

  • Next-generation degradable 3D meshes to repair POP

    A debilitating condition affecting one in four women is desperately crying out for a solution, and the next generation of treatments to repair the damage of pelvic organ prolapse (POP) has just come a big step closer.…  Read more

    Dr Kallyanashis Paul is a POP researcher in the Translational Tissue Engineering Research group in The Ritchie Centre.

  • Genetic analysis CAPS search for a cure

    A rare and debilitating group of autoinflammatory diseases is closer to a cure thanks to a world first genetic analysis project at Hudson Institute.…  Read more

    Professor Seth Masters and Dr Shouya Feng

  • Too much of a good thing: fine-tuning newborn resuscitation

    Latest research at Hudson found that a simple change in how oxygen therapy is given can help protect the babies brain during newborn resuscitation.…  Read more

    Dr Shiraz Badurdeen, Professor Graeme Polglase and Dr Emily Camm

  • Stem Cells: Hope on the horizon for preterm babies

    Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.…  Read more

    Dr Lindsay Zhou and Associate Professor Atul Malhotra

  • Uncovering the cellular secrets of RNA editing

    Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.…  Read more

    L-R: Scott Taylor, Ankita Goradia, Jacki Heraud-Farlow and Carl Walkley